Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MF59 is a squalene-based oil-in-water emulsion adjuvant widely used in human vaccines, particularly for influenza. It enhances both the magnitude and quality of immune responses to co-administered antigens by inducing chemokines and inflammatory cytokines, promoting danger signal release, and stimulating the differentiation of Mo-DCs. It is considered safe and well-tolerated in humans and enhances protective immunity against viral strains.
Enhances immune responses to co-administered antigens through chemokine/cytokine induction, danger signal release (ATP), and differentiation of monocyte-derived dendritic cells (Mo-DCs).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Squalene-based Oil-in-Water Emulsion (MF59) (MF59).